Quarterly report pursuant to Section 13 or 15(d)

Commitments and Contingencies - Additional Information (Details)

v3.20.2
Commitments and Contingencies - Additional Information (Details)
1 Months Ended 6 Months Ended
Oct. 08, 2019
Feb. 17, 2017
USD ($)
Jul. 09, 2015
USD ($)
Sep. 12, 2013
USD ($)
Jun. 17, 2016
USD ($)
Feb. 15, 1999
USD ($)
Jun. 30, 2020
USD ($)
ft²
Jun. 30, 2019
USD ($)
Dec. 31, 2019
USD ($)
Sep. 26, 2018
USD ($)
Jul. 06, 2016
ft²
Commitments and Contingencies [Line Items]                      
Area of Land | ft²                     2,300
Lease Expiration Period 120 days                    
Payment of annual fee       $ 30,000              
Intangible Assets, Net (Excluding Goodwill)             $ 4,118,564   $ 4,131,064    
Cease Payments Not Yet Paid Based On Prevailing Financial Market Conditions             10.00%        
Contract with Customer, Liability, Revenue Recognized               $ 2,686,000      
License [Member]                      
Commitments and Contingencies [Line Items]                      
Cost of Goods and Services Sold       $ 50,000 $ 15,000 $ 12,500          
Minimum [Member] | License [Member]                      
Commitments and Contingencies [Line Items]                      
Cost of Goods and Services Sold         5,000            
Maximum [Member] | License [Member]                      
Commitments and Contingencies [Line Items]                      
Cost of Goods and Services Sold         $ 20,000            
New Valeant Agreement                      
Commitments and Contingencies [Line Items]                      
Payment of annual fee   $ 4,000,000                  
Contract with Customer, Liability, Revenue Recognized   $ 99,000,000                  
Licensor [Member]                      
Commitments and Contingencies [Line Items]                      
Area of Land | ft²             4,516        
SentrX Animal Care Inc                      
Commitments and Contingencies [Line Items]                      
Intangible Assets, Net (Excluding Goodwill)             $ 250,000     $ 250,000  
Intangible Assets Expected Milestone Payable             $ 4,750,000     $ 4,750,000  
Valeant Pharmaceuticals International Inc [Member] | License [Member]                      
Commitments and Contingencies [Line Items]                      
Payments to Acquire Intangible Assets     $ 1,000,000                
Proceeds from Sale of Intangible Assets     $ 32,500,000